August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
May 22, 2023
The University of Cincinnati Cancer Center's Emily Curran recently provided commentary, highlighted by MedPage Today, on a study that showed a combination of antibody-drug conjugate and chemotherapy treatments were promising for older patients with B-cell acute lymphocytic leukemia.
April 26, 2023
WFMZ-TV in Allentown, Pennsylvania highlighted the University of Cincinnati's John Byrd and the Beat AML study testing personalized treatment for patients with acute myelogenous leukemia.